What is the current stock price of Alexander's, Inc. (ALX)?

As of the latest market data, Alexander's, Inc. (ALX) is trading at $248.05. The stock has seen a loss of -1.64% today.

Does Alexander's, Inc. (ALX) pay a dividend?

Based on current data, Alexander's, Inc. does not have a confirmed active dividend policy.

What is the market cap of Alexander's, Inc.?

The current market capitalization of Alexander's, Inc. (ALX) is approximately unavailable.

ALX

Alexander's, Inc.·Real Estate

248.05

1.642%(−4.14)

Market Open

Last Updated: — ET

52W L: $201.2852W H: $260.84

ALX NEWS

forbes.com

May 17

The Most Hated High Yields On Wall Street

Let's capitalize on analyst incompetence—and bank yields up to 18.3%, with upside to boot!

Company Profile

Alexander's, Inc. is a real estate investment trust which has seven properties in the greater New York City metropolitan area.

Sector

Real Estate

Industry

REIT - Retail

Employees

IPO Date

1973-02-21

Beta

0.77

Websitewww.alx-inc.com↗

marketbeat.com

May 8

ALX Oncology Q1 Earnings Call Highlights

ALX Oncology NASDAQ: ALXO executives used the company's first-quarter 2026 earnings call to highlight new clinical data for its lead CD47 blocker, evorpacept, and to provide updates on its EGFR-targeted antibody-drug conjugate program, ALX2004. CEO Jason Lettmann said the quarter featured “continued good execution,” including a February financing and the addition of Jeff Knight as chief development and chief operating officer.

ALX

The Most Hated High Yields On Wall Street

The Most Hated High Yields On Wall Street

ALX Oncology Q1 Earnings Call Highlights

ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update

ALX Oncology's Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression

Alexander's (ALX) Q1 FFO and Revenues Lag Estimates

A Look at Alexander's Inc (ALX) After 3.0% Decline -- GF Value $203.84 vs Price $244.34